首页 | 本学科首页   官方微博 | 高级检索  
检索        

3种抗菌药物治疗非淋茵性泌尿生殖道炎的成本-效果分析
引用本文:吴再炎,孙庭.3种抗菌药物治疗非淋茵性泌尿生殖道炎的成本-效果分析[J].中国医院用药评价与分析,2001,1(3):155-156.
作者姓名:吴再炎  孙庭
作者单位:1. 深圳市华侨城医院,
2. 广州市性康复中心,
摘    要:目的探讨不同药物治疗方法对相同疾病的经济效果。方法选择120例非淋菌性泌尿生殖道炎患者,随机分为3组,分别给予左氧氟沙星、克拉霉素、米诺环素治疗,运用药物经济学的成本-效果分析方法进行评价。结果克拉霉素是治疗非淋菌性泌尿生殖道炎的较佳药物。结论药物经济学在优化治疗方案、指导临床合理用药、提高经济效益方面具有重要作用。

关 键 词:药物经济学  成本-效果分析  非淋菌性泌尿生殖道炎
文章编号:2001-03-0155-02
修稿时间:2001年5月21日

Cost-effectiveness Analysis of Three Antibacterial Agents for Nongonococal Urogenital Infections
WU Zaiyan.Cost-effectiveness Analysis of Three Antibacterial Agents for Nongonococal Urogenital Infections[J].Evaluation and Analysis of Drug-Use in Hospital of China,2001,1(3):155-156.
Authors:WU Zaiyan
Abstract:OBJECTIVE:To discuss the economical effects of different medication on the treatment of the same illness.METHODS: 120 patients of nongonococal urethritis or cervicitis were randomly divided into three groups, group A; levofloxacin, group B; clarithromycin, group C: minocyclin.Data was evaluated with the pharmacoeconomic cost-effectiveness analysis. RESULTS: Clarithromycin was the best medicine to treat nongonococal urethritis or cervicitis.CONCLUSION: The phar-macoeconomics plays an important role in optimizing therapeutic scheme, guiding rational drug use and raising economic benefit.
Keywords:nongonococal urogenital infections  cost-effectiveness analysis  pharmacoeconomics  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号